Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27.
Mingli Xu, Izuru Mizoguchi, Noriko Morishima, Yukino Chiba, Junichiro Mizuguchi, Takayuki Yoshimoto
Author Information
Mingli Xu: Intractable Disease Research Center, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
中文译文
English
The interleukin (IL)-12 family, which is composed of heterodimeric cytokines including IL-12, IL-23, and IL-27, is produced by antigen-presenting cells such as macrophages and dendritic cells and plays critical roles in the regulation of helper T (Th) cell differentiation. IL-12 induces IFN-�� production by NK and T cells and differentiation to Th1 cells. IL-23 induces IL-17 production by memory T cells and expands and maintains inflammatory Th17 cells. IL-27 induces the early Th1 differentiation and generation of IL-10-producing regulatory T cells. In addition, these cytokines induce distinct immune responses to tumors. IL-12 activates signal transducers and activator of transcription (STAT)4 and enhances antitumor cellular immunity through interferon (IFN)-�� production. IL-27 activates STAT1, as does IFN-�� and STAT3 as well, and enhances antitumor immunity by augmenting cellular and humoral immunities. In contrast, although exogenously overexpressed IL-23 enhances antitumor immunity via memory T cells, endogenous IL-23 promotes protumor immunity through STAT3 activation by inducing inflammatory responses including IL-17 production.
J Clin Oncol. 1995 Mar;13(3):688-96
[PMID: 7884429 ]
Trends Immunol. 2007 May;28(5):207-12
[PMID: 17395538 ]
Cancer Cell. 2009 Feb 3;15(2):81-3
[PMID: 19185840 ]
N Engl J Med. 1987 Apr 9;316(15):889-97
[PMID: 3493432 ]
J Immunol. 2006 Jun 15;176(12):7317-24
[PMID: 16751375 ]
Toxicol Pathol. 1999 Jan-Feb;27(1):58-63
[PMID: 10367675 ]
Cytokine Growth Factor Rev. 2002 Apr;13(2):155-68
[PMID: 11900991 ]
Mol Immunol. 2009 May;46(8-9):1654-62
[PMID: 19299021 ]
Immunity. 2002 Jun;16(6):779-90
[PMID: 12121660 ]
Nature. 2006 May 11;441(7090):235-8
[PMID: 16648838 ]
Immunity. 2003 Nov;19(5):641-4
[PMID: 14614851 ]
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43
[PMID: 8097319 ]
Nature. 2006 Jul 27;442(7101):461-5
[PMID: 16688182 ]
Immunol Rev. 2008 Dec;226:248-62
[PMID: 19161429 ]
J Immunol. 2005 Aug 1;175(3):1686-93
[PMID: 16034109 ]
J Biomed Biotechnol. 2010;2010:605483
[PMID: 20454646 ]
J Immunol. 2007 Oct 1;179(7):4415-23
[PMID: 17878337 ]
J Immunol. 2004 Dec 15;173(12):7170-82
[PMID: 15585838 ]
Cancer Res. 2006 Jun 15;66(12):6395-404
[PMID: 16778218 ]
Scand J Immunol. 2008 Jul;68(1):22-9
[PMID: 18482209 ]
Cancer Cell. 2009 Feb 3;15(2):114-23
[PMID: 19185846 ]
J Immunol. 2009 Nov 15;183(10):6217-26
[PMID: 19841177 ]
J Immunol. 2004 Nov 1;173(9):5626-34
[PMID: 15494513 ]
Blood. 2006 Aug 1;108(3):804-11
[PMID: 16861339 ]
J Immunol. 2007 Dec 1;179(11):7215-9
[PMID: 18025162 ]
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6808-12
[PMID: 2204066 ]
Nat Immunol. 2006 Sep;7(9):929-36
[PMID: 16906167 ]
Immunity. 2000 Nov;13(5):715-25
[PMID: 11114383 ]
J Exp Med. 1993 Oct 1;178(4):1223-30
[PMID: 8104230 ]
Clin Exp Immunol. 2000 Jan;119(1):28-37
[PMID: 10606961 ]
Gastroenterology. 2007 Jun;132(7):2359-70
[PMID: 17570211 ]
Nat Immunol. 2007 Dec;8(12):1372-9
[PMID: 17994023 ]
Int J Cancer. 2003 Jul 20;105(6):820-4
[PMID: 12767068 ]
J Immunol. 2008 May 15;180(10):6527-35
[PMID: 18453571 ]
Nat Rev Immunol. 2007 Jan;7(1):41-51
[PMID: 17186030 ]
Nature. 2003 Feb 13;421(6924):744-8
[PMID: 12610626 ]
J Exp Med. 1989 Sep 1;170(3):827-45
[PMID: 2504877 ]
Annu Rev Immunol. 1995;13:251-76
[PMID: 7612223 ]
Nat Immunol. 2006 Sep;7(9):937-45
[PMID: 16906166 ]
J Biol Chem. 2003 Jan 17;278(3):1910-4
[PMID: 12417590 ]
Clin Immunol Immunopathol. 1997 Apr;83(1):18-20
[PMID: 9073529 ]
J Immunol. 2005 Aug 15;175(4):2191-200
[PMID: 16081786 ]
Annu Rev Immunol. 1998;16:495-521
[PMID: 9597139 ]
Nat Immunol. 2007 Dec;8(12):1363-71
[PMID: 17994025 ]
Nature. 2006 May 11;441(7090):231-4
[PMID: 16648837 ]
Clin Cancer Res. 2003 Jan;9(1):76-83
[PMID: 12538454 ]
Int J Cancer. 2009 Mar 15;124(6):1372-8
[PMID: 19089917 ]
J Immunol. 1991 May 1;146(9):3074-81
[PMID: 1673147 ]
Lancet. 2001 Feb 17;357(9255):539-45
[PMID: 11229684 ]
J Immunol. 2007 Jun 15;178(12):7571-80
[PMID: 17548592 ]
J Clin Invest. 2001 Jul;108(1):51-62
[PMID: 11435457 ]
Immunity. 2003 Nov;19(5):645-55
[PMID: 14614852 ]
Semin Cell Dev Biol. 2008 Aug;19(4):394-400
[PMID: 18708155 ]
Nat Rev Cancer. 2004 Feb;4(2):97-105
[PMID: 14964307 ]
Immunity. 2003 Nov;19(5):657-67
[PMID: 14614853 ]
Ann Intern Med. 1988 Apr;108(4):518-23
[PMID: 3258138 ]
Nat Rev Immunol. 2006 Apr;6(4):295-307
[PMID: 16557261 ]
Nature. 2007 Feb 8;445(7128):648-51
[PMID: 17187052 ]
J Immunol. 2003 Jul 15;171(2):600-7
[PMID: 12847224 ]
Cancer Res. 2004 Feb 1;64(3):1152-6
[PMID: 14871851 ]
J Immunol. 2004 Sep 15;173(6):3871-7
[PMID: 15356135 ]
Cancer Res. 2009 Mar 15;69(6):2523-30
[PMID: 19244121 ]
J Immunol. 2003 May 15;170(10):4886-90
[PMID: 12734330 ]
Anticancer Res. 2004 Nov-Dec;24(6):3763-7
[PMID: 15736409 ]
Am J Pathol. 1995 Dec;147(6):1693-707
[PMID: 7495294 ]
J Virol. 2004 Sep;78(17):9093-104
[PMID: 15308705 ]
Nat Immunol. 2007 Dec;8(12):1380-9
[PMID: 17994022 ]
Nature. 2007 Nov 22;450(7169):566-9
[PMID: 18033300 ]
J Immunol. 2008 Mar 1;180(5):2752-6
[PMID: 18292493 ]
Mol Ther. 2005 Jul;12(1):18-27
[PMID: 15963916 ]
J Immunol. 2009 Apr 1;182(7):4328-38
[PMID: 19299733 ]
Int J Cancer. 2005 Jun 20;115(3):437-42
[PMID: 15688376 ]
Antigen-Presenting Cells
Cell Differentiation
Gene Expression Regulation
Humans
Interleukin-12
Interleukin-17
Interleukin-23
Neoplasms
T-Lymphocytes, Helper-Inducer
Interleukin-17
Interleukin-23
Interleukin-12